Keyphrases
Rapamycin
100%
Cellular Phenotype
100%
Progerin
100%
Hutchinson-Gilford Progeria Syndrome
100%
Temsirolimus
100%
DNA Damage
50%
Mitochondrial Function
25%
Amino Acids
25%
Autophagy
25%
Myocardial Infarction
25%
Carboxyl Terminus
25%
Future Therapeutics
25%
Morphological Changes
25%
Mitochondrial Dysfunction
25%
Therapeutic Strategies
25%
Functional Change
25%
Pharmacokinetic Profile
25%
Treatment Regimen
25%
DNA Transcription
25%
New Drugs
25%
DNA Replication
25%
Proteasome Activity
25%
Proteostasis
25%
Combination Regimen
25%
Drug Treatment
25%
Cellular Senescence
25%
Drug Combination
25%
Lamin
25%
Mammalian Target of Rapamycin (mTOR)
25%
Premature Aging
25%
Nuclear Envelope
25%
Prelamin A
25%
LMNA Gene
25%
LMNA mutation
25%
Rapamycin Analogs
25%
Terminal Region
25%
Age-related Illnesses
25%
Misshapen nuclei
25%
Biochemistry, Genetics and Molecular Biology
Progerin
100%
Progeria
100%
LMNA
50%
DNA Damage
50%
Amino Acids
25%
Mitochondrial Disorder
25%
Morphology
25%
Protein Homeostasis
25%
Nuclear Pore
25%
DNA Transcription
25%
Nuclear Membrane
25%
C-Terminus
25%
Proteasome
25%
Lamin
25%
Autophagy
25%
DNA Synthesis
25%
Pharmacokinetics
25%
Mechanistic Target of Rapamycin
25%
Pharmacology, Toxicology and Pharmaceutical Science
Progeria
100%
Rapamycin
100%
Temsirolimus
100%
Diseases
40%
Pharmacotherapy
20%
Amino Acid
20%
Prematurity
20%
Heart Infarction
20%
Premature Aging
20%
Cerebrovascular Accident
20%
Mammalian Target of Rapamycin
20%
Lamin
20%
Proteasome
20%
Combination Drug
20%
Pharmacokinetics
20%